36.80

4.29% -1.65

After Hours: 36.80

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $36.80, with a volume of 747.22K. It is down -4.29% in the last 24 hours and down -13.08% over the past month. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Previous Close:

$38.45

Open:

$38.37

24h Volume:

747.22K

Relative Volume:

0.69

Market Cap:

$2.38B

Revenue:

$277.49M

Net Income/Loss:

$-192.14M

P/E Ratio:

-10.95

EPS:

-3.36

Net Cash Flow:

$-95.52M

1W Performance:

+0.46%

1M Performance:

-13.08%

6M Performance:

-19.16%

1Y Performance:

+28.81%

1-Day Range:

$36.58

$38.37

1-Week Range:

$36.07

$40.85

52-Week Range:

$27.41

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1151)

Industry

Diagnostics & Research (58)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

923

Twitter

@TwistBioscience

Next Earnings Date

2025-02-03

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	36.80	2.38B	277.49M	-192.14M	-95.52M	-3.36
TMO Thermo Fisher Scientific Inc	427.50	169.62B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	186.83	138.06B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	411.49	32.79B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	102.48	29.99B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	143.91	26.61B	15.41B	1.37B	2.11B	7.50

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

03:04 AM

Is Twist Bioscience Corp (NASDAQ: TWST) A Good Pick For New Investors Now? - Stocksregister

03:04 AM

Apr 16, 2025

Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Alliancebernstein L.P. - Defense World

Apr 16, 2025

Apr 15, 2025

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Apr 15, 2025

LPL Financial LLC Has $2.32 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Apr 15, 2025

Apr 14, 2025

Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 - Business Wire

Apr 14, 2025

Apr 11, 2025

Twist Bioscience CFO Sells Shares to Cover Tax Obligations - TradingView

Apr 11, 2025

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.

Apr 11, 2025

Twist Bioscience (NASDAQ:TWST) Trading Down 12.1% After Analyst Downgrade - Defense World

Apr 11, 2025

Apr 05, 2025

Twist Bioscience president sells $7,978 in stock - Investing.com Australia

Apr 05, 2025

Twist Bioscience’s chief legal officer sells shares for $4,802 - Investing.com Australia

Apr 05, 2025

Twist Bioscience’s chief legal officer sells shares for $4,802 By Investing.com - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Twist Bioscience president sells $7,978 in stock By Investing.com - Investing.com Canada

Apr 04, 2025

Twist Bioscience CEO Sells Shares to Cover Tax Obligations - TradingView

Apr 04, 2025

Mar 31, 2025

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics - Business Wire

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 28, 2025

Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells 1,726 Shares of Stock - MarketBeat

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 25, 2025

Twist Bioscience’s SVP of human resources sells $12,127 in stock - Investing.com India

Mar 25, 2025

Mar 24, 2025

Twist Bioscience CEO Emily Leproust sells $71,932 in shares By Investing.com - Investing.com South Africa

Mar 24, 2025

Twist Bioscience CEO Emily Leproust sells $71,932 in shares - Investing.com India

Mar 24, 2025

Twist Bioscience’s Dennis Cho sells $9,585 in common stock By Investing.com - Investing.com Canada

Mar 24, 2025

Twist Bioscience’s SVP of human resources sells $12,127 in stock By Investing.com - Investing.com Australia

Mar 24, 2025

Twist Bioscience’s Dennis Cho sells $9,585 in common stock - Investing.com

Mar 24, 2025

Mar 20, 2025